Conmed (CNMD) Tops Q2 EPS by 27c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts CNMD Hot Sheet
Price: $45.72 --0%
Financial Fact:
Research and development expense: 8.35M
Today's EPS Names:
NXTC, ALLO, KTB, More
Financial Fact:
Research and development expense: 8.35M
Today's EPS Names:
NXTC, ALLO, KTB, More
Join SI Premium – FREE
Conmed (NYSE: CNMD) reported Q2 EPS of $1.38, $0.27 better than the analyst estimate of $1.11. Revenue for the quarter came in at $343.5 million versus the consensus estimate of $337.46 million.
GUIDANCE:
Conmed sees FY2026 EPS of $4.48-$4.60, versus the consensus of $4.34. Conmed sees FY2026 revenue of $1.36-1.37 billion, versus the consensus of $1.36 billion.
For earnings history and earnings-related data on Conmed (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Magna International (MGA) Tops Q3 EPS by 25c ; Offers Guidance
- H.C. Wainwright Reiterates Buy Rating on Strategy (MSTR)
- Firstsource Solutions Ltd (FSOL:IN) PT Raised to INR250 at Kotak
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
